TNFRSF8 and lymphoproliferative syndrome: From a diagnostic standpoint, the case reinforces the necessity of integrating detailed lesion morphology, immunohistochemistry with percentage, intensity, and distribution, and a focused differential diagnosis to distinguish MF from other cutaneous lymphoproliferative disorders such as CD30+ lymphoproliferative disease.